CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations

NCT00943488 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

408

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Inactivated H1N1 Vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)